The Impact of the Pro- and Anti-Inflammatory Immune Response on Ventilation Time after Cardiac Surgery

Cytometry Part B - Clinical Cytometry

Volumn 53, Issue 1, 2003, Pages 70-74

  Rothenburger, Markus ^a   Tjan, Tonny D T ^a   Schneider, Michael ^a   Berendes, Elmar ^a   Schmid, Christof ^a   Wilhem, Markus J ^a   Böcker, Dirk ^a   Scheld, Hans Heinrich ^a   Soeparwata, Rasjid ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cardiac surgery; Infection; Intensive care medicine; Predictive medicine; Pro and anti inflammatory cytokines

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CYTOKINE RELEASE; FEMALE; GERMANY; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICINE; MORBIDITY; PILOT STUDY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VENTILATOR; BLOOD; IMMUNE SYSTEM; IMMUNOLOGY; INFECTION; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; ROC CURVE;

AGED; CARDIOPULMONARY BYPASS; ENDOTOXINS; FEMALE; HUMANS; IMMUNE SYSTEM; INFECTION; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RESPIRATION, ARTIFICIAL; ROC CURVE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0242407930     PISSN: 15524949     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.b.10027     Document Type: Article

References (21)

1. Deng MC, Dasch B, Erren M, Möllhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 1996;62:184-190.
2. Westaby S. Organ dysfunction after cardiopulmonary bypass: a systemic inflammatory reaction induced by the extracorporeal circuit. Int Care Med 1987;13:89-95.
3. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-1016.
4. El Azab SR, Rosseel PM, deLange JJ, Groeneveld AB, van Strik R, van Wijk EM, Scheffer GJ. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002;88:496-501.
5. Borgermann J, Friedrich I, Flohe S, Spillner J, Majetschak M, Kuss A, Sablotzki A, Feldt T, Reidemeister JC, Schade FU. Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: down regulation caused by circulating cytokine-inhibitor activities. J Thorac Cardiovasc Surg 2002;124:608-617.
6. Wan S, LeClerc JL, Vincent JL. Cytokine response to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63:269-276.
7. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield IJ, Rankin JS. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularisation. J Thorac Cardiovasc Surg 1994;108:26-35.
8. Nathan N, Preux PM, Feiss P, Denziot Y. Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000;14:156-160.
9. Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TDT, Wilhelm MJ, Erren M, Böcker D, Scheld HH. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 2001;38:124-130.
10. Kawamura T, Wakusawa R, Inada K. Interleukin-10 and interleukin-1 receptor antagonist increase during cardiac surgery. Can J Anaesth 1997;44:38-42.
11. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995;75:724-733.
12. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997;24:328-332.
13. van der Poll T, de Waal Malefyt R, Coyle SM, Lowry SF. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis 1997;175:118-122.
14. McBride WT, Armstrong MA, Gilliland H, McMurray TJ. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. Cytokine 1996;8:724-729.
15. Nathan N, Denizot Y, Cornu E, Jauberteau MO, Chauvreau C, Feiss P. Cytokine and lipid mediator blood concentrations after coronary artery surgery. Anesth Analg 1997;85:1240-1246.
16. Wan S, LeClerc JL, Schmartz D, Barvais L, Huynh CH, Deviere J, deSmet JM, Vincent JL. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997;133:335-339.
17. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993;56:92-96.
18. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmont JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-641.
19. Mishoph M, Babin-Ebell J. Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 1997;12:119-127.
20. Valet G. Predictive medicine by cytomics: potential and challenges. J Biol Regul Homeost Agents 2002;16:164-167.
21. Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tarnok A. Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care 2002;6:226-233.